Firms

Lightswitch Capital
New York, New York, United States
Lightswitch Capital is a New York investment manager and long-term partner to private healthcare companies. Its legal adviser is Lightswitch Capital Management, L.P., a Delaware limited partnership reporting to the SEC as an exempt reporting adviser under CRD319223. Its healthcare investments include precision neuropsychiatry company Alto Neuroscience, gene therapy engineering company Kriya Therapeutics and antibody-platform company Hinge Bio. Current regulatory disclosures identify Christopher Nixon Cox as chief executive officer and general partner, Bo Cui as chief operating officer, and Pamela Louise Rockley as chief compliance officer. Rockley provides compliance services through her consulting business; she is included as a regulatory officer rather than an investment partner. The adviser reports one Cayman Islands private fund, Lightswitch Capital Fund I, L.P., with Lightswitch Capital GP, LLC as general partner. Public fund assets do not establish its final commitments or closing date. The firm is distinct from unrelated businesses using the Lightswitch name.
- Founded
- —
- Type
- Venture capital






